Example of an End-of-Treatment Consultation Note: Hodgkin’s Disease

Date of note: April 15, 2005

Name: Jane Smith Age: 28

Date of tissue diagnosis of cancer: November 15, 2004


Diagnosis: Hodgkin’s disease

Stage of cancer: Clinical stage IIA

Pathologic findings: Classical Hodgkin’s disease


Initial treatment plan:

  • Surgery: Biopsy, left supraclavicular lymph note

  • Radiation therapy: 30 Gy radiation, to modified mantle field (i.e., bilateral supraclavicular and mediastinal), as consolidation after chemotherapy

  • Chemotherapy: Stanford V chemotherapy for 12 weeks

Treatment received (specify dates, location, and providers):

Stanford V chemotherapy 12/1/04–3/2/05; full doses, on schedule; Dr. Kay, Eastern University Medical Center

Radiation therapy 3/15/05–4/15/05; Dr. Smith, Eastern University Medical Center


Unusual or unexpected toxicities during treatment:

None


Expected short- and long-term effects of treatment:

Short term—partial alopecia, hospitalization for fever with neutropenia, 2/15/05 to 2/17/05—given granulocyte colony-stimulating factor and red blood cell transfusion.


Late toxicity monitoring needed:

Thyroid function tests, annually—thyroid-stimulating hormone (TSH) and free T4.

Pulmonary function tests and echocardiograms are not customary or recommended to perform routinely. In particular, it is established that pulmonary function tests within 12 months of thoracic radiation may show mild abnormalities which improve over time.

Careful auscultation of the heart is recommended during follow-up, particularly for patients receiving chest irradiation and anthracycline chemotherapy.

Assessment of fertility—birth control pills for at least 2 years. Monitoring of menstrual functioning. Referral to GYN if requested.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement